Article Details

Takara Bio grants BioNTech a commercial patents license of CAR T-cell Therapy drug

Retrieved on: 2021-06-25 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

Takara Bio grants BioNTech a commercial patents license of CAR T-cell Therapy drug. View article details on hiswai:

Excerpt

The patented technologies licensed to BioNTech are based on Takara Bio's proprietary RetroNectin® method, which includes a technology enabling ...

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up